Why the study?
Do ACE inhibitors prevent the progression of renal failure and development of macroalbuminuria in patients with diabetes mellitus?
Do ACE inhibitors prevent the progression of renal failure and development of macroalbuminuria in patients with diabetes mellitus?
ACE inhibitors provide renoprotective benefits beyond blood pressure lowering and are considered the drugs of choice in diabetic patients with hypertension or renal dysfunction.
Answers are grounded in this paper and cite their sources.
Supports ACE inhibitor preference in diabetic nephropathy; extends prior data but hypothesis-generating pending prospective trials.
AIM: To review recent studies on the effect of angiotensin converting enzyme (ACE) inhibitors on diabetic nephropathy. METHOD: Literature review. RESULTS: Strict glucose control, a low protein intake and aggressive blood pressure control are the main requirements for the preservation of renal function in patients with diabetes mellitus. Recent work has shown that ACE inhibitors have renoprotective actions in diabetes that go beyond their capacity to lower blood pressure. Through these actions they slow the progression of renal failure and prevent the development of macroalbuminuria that characterizes the onset of diabetic nephropathy. CONCLUSIONS: ACE inhibitors may be considered the drugs of choice in diabetic patients with either hypertension or some degree of renal dysfunction.
No takes yet. Share an insight, caveat, or question.
Luís M. Ruilope (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: